switch of the vascular transcriptome and consequently development of CVD. Brahma related gene 1 (Brg1) and Brahma (Brm) are core components of the chromatin remodeling complex that uses ATP hydrolysis to alter the positioning of nucleosomes and, in so doing, dictates the outcome of transcription events taking place within the vasculature. 10 Ramirez-Carrozzi et al 11 have previously reported that Brg1 and Brm are involved in lipopolysaccharide (LPS)-induced inflammatory response in macrophages. 11 Recent investigations have implicated Brg1 and Brm in both organogenesis and disease development in the cardiovascular system. [12] [13] [14] Here we report that augmented expression of Brg1/Brm was observed in inflammation-challenged endothelial cells in vitro and in vivo. Brg1 and Brm, functioning as cofactors for NF-κB, help orchestrate key epigenetic events that result in CAM transactivation. Silencing of Brg1/Brm in vivo contributes to alleviated phenotypes in an animal model of atherosclerosis. Therefore, our data provide clear evidence implicating Brg1/Brm as a common link in inflammation-induced endothelial dysfunction.
Methods
An expanded Methods section can be found in the Online Data Supplement. Briefly, human umbilical vein endothelial cell (HUVEC; EAhy926), human aortic artery endothelial cell (HAEC), human embryonic kidney cell (HEK293), and the Brg1/Brm-negative adenoma cell (SW-13) were maintained according to the vendors' recommendations. Promoter activity was measured by transfection reporter assays. Expression of mRNA and protein was measured by real-time quantitative PCR and Western blotting, respectively. Interaction between endothelial cells and leukocytes was assessed by leukocyte adhesion assay in vitro and immunostaining in vivo. Knockdown of endogenous proteins was mediated by either small interfering RNA (siRNA) or short hairpin RNA carried by lentiviral particles. Protein binding to DNA was assayed by DNA affinity pulldown assay and chromatin immunoprecipitation (ChIP) assay. Apoe -/mice were fed a high-fat diet for 6 to 8 weeks to induce atherosclerosis. All animal experiments have been performed following guidelines by the intramural Committee on Ethical Conduct of Animal Studies.
Results

Proinflammatory Stimuli Activate the Expression of Brg1 and Brm in Endothelial Cells
To assess the relevance of Brg1/Brm in the activation of adhesion molecules in endothelial cells, we first measured the expression of Brg1 and Brm in response to proinflammatory stimuli. Treatment of HUVEC (EAhy926) with tumor necrosis factor α (TNF-α), oxLDL, or LPS all led to significant induction of Brg1 and Brm levels ( Figure 1A Figure  IA ). Interestingly, 17β-estradiol (E2), known to curb the inflammatory response in the vascular endothelium, 15 tampered the upregulation of Brg1/Brm expression (Online Figure IC) . More importantly, Brg1 and Brm levels were elevated in arteries in vivo in rodents challenged with inflammatory stress ( Figure 1D and 1E; Online Figure ID ). Collectively, these data illustrate that expression levels of Brg1 and Brm might be correlated with intracellular inflammatory state.
Brg1 and Brm Are Involved in the Transcriptional Activation of Adhesion Molecules by Proinflammatory Stimuli
Having observed that the expression of Brg1 and Brm was upregulated by proinflammatory stimuli in endothelial cells, we next evaluated the role of Brg1 and Brm in inflammation-induced CAM expression. By themselves, neither Brg1 nor Brm impacted promoter activities of adhesion molecules; they, however, potently augmented promoter activities of adhesion molecules in the presence of an individual proinflammatory signal (Online Figure IIA) . The catalytic moiety of Brg1/Brm was clearly required for their function because enzyme-deficient forms of Brg1 and Brm failed to activate TNF-α-dependent transcription of CAM genes (Figure 2A ). Coexpression of Brg1 and Brm resulted in additional activation of CAM promoters (Online Figure  IIB) . Similar results were obtained in HUVECs treated with oxLDL or LPS ( Figure 2B ), suggesting that Brg1/Brm may be a common link in inflammation-induced transactivation of CAMs. In further support of this notion, overexpression of Brg1 and Brm in HUVECs enhanced activation of endogenous CAM expression in the presence of proinflammatory stimuli both at the mRNA level ( Figure 2C Figure IIID ) treated with TNF-α. Of note, codepletion of Brg1 and Brm did not achieve additional suppression, indicating that proteins other than Brg1/Brm may become a rate-limiting factor when Brg1/ Brm levels are sufficiently low. As a result, adhesion of leukocytes was severely crippled in the absence of Brg1/Brm ( Figure 3F ). Consistently, knockdown of Brg1/Brm also abolished activation of CAM message levels by oxLDL (Online Figure IIIE 
Brg1 and Brm Interact With and Are Recruited to the Promoters by p65 and Stabilize p65
All 3 promoter constructs used in this study (Figure 2A ) harbor a conserved NF-κB site, alluding to the possibility that Brg1 and Brm may interact with and be recruited to the CAM promoters by NF-κB. Indeed, coimmunoprecipitations confirmed that Brg1/Brm formed a complex with p65 (Online Figure IVA and IVB). Inflammatory stimuli augmented occupancies of Brg1 and Brm to regions where NF-κB/p65 binds on all 3 CAM promoters as evidenced by ChIP assays ( Figure 4A ; Online Figure IVC ). In contrast, there was less binding of Brg1/Brm on the intronic regions of CAM genes, and the binding was not responsive to inflammatory signals ( Figure 4A ; data not shown). Importantly, ex vivo ChIP assay revealed that there was more binding of Brg1 and Brm on the intercellular adhesion molecule 1 (ICAM-1) promoter in arteries isolated from mice that developed atherosclerosis ( Figure 4B ). Of note, consistent with its ability to curtail A, Promoter luciferase fusion constructs for intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin genes were transfected into human umbilical vein endothelial cells (HUVECs) with either siRNA targeting Brg1 or Brm or scrambled siRNA (SCR) as indicated followed by treatment with tumor necrosis factor α (TNF-α). Luciferase activities were expressed as normalized relative luciferase unit (NRLU); *P<0.01. B-E, HUVECs were transfected with siBrg1, siBrm, or SCR followed by treatment with TNF-α. mRNA (B) and protein (C) levels of CAMs were assessed by quantitative PCR and Western blotting. Similar experiments were performed in human aortic artery endothelial cells (HAECs; D, E); *P<0.01. F, HUVECs were transfected with siBrg1, siBrm, or SCR followed by treatment with TNF-α. Leukocyte adhesion assay was performed as described under Methods. Data are shown as mean+SD of triplicates and are representative of 1 experiment out of 3 performed.
( Figure 5B ; Online Figure VC and VD). In aggregate, this line of data supports a dynamic complex formed by Brg1, Brm, and p65 on the CAM promoters in response to inflammatory cues.
Brg1 and Brm Coordinate Key Epigenetic Alterations in Response to Proinflammatory Stimuli
Because Brg1 and Brm constitute a key component of the epigenetic machinery, we examined how depletion of Brg1 and Brm would impact the chromatin structure of the CAM genes. Specific siRNA for Brg1 or Brm significantly reduced their association with the CAM chromatin in response to TNF-α (Online Figure VIA) . Consequently, active histone markers including acetylated histone H3 and methylated histone H3 lysine 4 were erased ( Figure 6A-C) . This was accompanied by impaired recruitment of the basic transcriptional machinery as evidenced by inefficient binding of RNA polymerase II. Curiously, levels of the histone variant H2A.Z that is commonly associated with active transcription was only modestly affected. In addition, elimination of Brg1 and Brm also abrogated active histone modifications and disrupted polymerase II binding on the CAM chromatin when endothelial cells were treated with oxLDL (Online Figure VIB and VIC) or LPS (Online Figure VID) . In all, these data strongly suggest that Brg1 and Brm contribute to CAM transactivation by maintaining a transcriptionally friendly chromatin environment for the accession of RNA polymerase.
Brg1 and Brm Deficiency Averts Detrimental Effects Exerted by Proinflammatory Stimuli In Vivo
Finally, we probed the in vivo relevance of Brg1-and Brmmediated CAM transactivation in atherosclerosis. To this end, we used an endothelial-specific targeting system to knock down Brg1/Brm in vivo. Indeed, infection of in vitro-cultured endothelial cells but not embryonic kidney cells resulted in suppression of Brg1/Brm expression (Online Figure VIIA) . Moreover, immunostaining also revealed marked downregulation of Brg1/Brm expression in the vascular endothelium (Online Figure VIIB) , but not in circulating leukocytes (Online Figure  VIIC) . With endothelial-specific silencing of Brg1/Brm, there was a significant reduction in atherosclerotic lesion in mice ( Figure 7A and 7B) . Concomitantly, expression of ICAM-1, VCAM-1, and E-selectin was normalized in the aortic arteries of atherosclerotic mice ( Figure 7C ). Consequently, adhesion of CD3 + lymphocytes, CD45 + activated leukocytes, and F4/80 + macrophages were reduced ( Figure 7D ). In aggregate, these data clearly support the notion that silencing of Brg1 and Brm stalled development of atherosclerosis by normalizing endothelial function in vivo.
Discussion
Inflammation-triggered, endothelium-dependent recruitment of leukocyte to the vessel wall and consequently the establishment of a proinflammatory milieu within the vasculature Figure 4 . Brahma related gene 1 (Brg1) and Brahma (Brm) interact with and are recruited to the promoters by p65. A, Human umbilical vein endothelial cells (HUVECs) were treated with tumor necrosis factor α (TNF-α) for 3 hours. Chromatin immunoprecipitation (ChIP) assays were performed with anti-Brg1, anti-Brm, or IgG. Precipitated DNA was amplified by primers spanning the promoter or intronic region of indicated CAM gene. B, C57/BL6 or Apoe -/mice were fed a high-fat diet diet for 8 weeks. Aortic arteries were isolated and ChIP assays were performed with indicated antibodies; n=3 for each group. C, HUVECs were transfected with sip65 or scrambled siRNA (SCR) followed by treatment with TNF-α for 3 hours. ChIP assays were performed with indicated antibodies. Data are shown as mean+SD of triplicates and are representative of 1 experiment out of 3 performed. September 27, 2013 represents a hallmark event in the pathogenesis of a range of CVDs. 17 Key to this process is the transactivation of adhesion molecules mediated by NF-κB in response to inflammatory stimuli. Here we report that epigenetic factors Brg1 and Brm contribute to inflammation-induced CAM transactivation and are critically involved in the pathogenesis of atherosclerosis.
By shaping up the chromatin structure, Brg1 and Brm play a versatile role in transcriptional regulation. Our data indicate that Brg1 and Brm represent an integral part of the proinflammatory program initiated by divergent injurious signals. Brg1 and Brm seem to be crucial in orchestrating key histone modifications indicative of an active transcription state that correlates with CAM upregulation (Figure 6 ; Online Figure  VIB ). It has been well documented that Brg1 and Brm are required for the recruitment and stabilization of several enzymes that catalyze the active histone marks, including MLL1 (H3K4 methylation), CBP (histone H3 and H4 acetylation), and p300 (histone H3 and H4 acetylation). [18] [19] [20] [21] These modifications combined likely set up the stage for the recruitment of the basic transcriptional machinery. In fact, 2 recent articles highlight the importance of Brg1/Brm in stress-induced gene expression. Naito et al 22 provide evidence that ischemic stress harnesses Brg1 to induce the expression in TNF-α and macrophage chemotactic protein-1 in renal epithelial cells. Meanwhile, He and Luo 23 point to the indispensability of Brg1 in human papilloma virus 18 E6/E7 gene expression in HeLa cells. Of particular interest, although Brg1 is responsible for RNA polymerase II recruitment to the TNF-α and MCP-1 promoters in response to ischemia without altering histone status, acetylation of histones H3 and H4 is clearly dependent on Brg1 for E6/E7 transactivation, which is more in line with our data presented here. Relying on extracellular and intracellular cues, Brg1 and Brm can be engaged in both active and repressive chromatin modification by switch binding partners. [24] [25] [26] Paradoxically, Fish et al 27 have reported that Brg1 helps restore endothelial nitric oxide synthase expression during hypoxia/reoxygenation cycle by preventing the eviction of acetylated histones H3 and H4 on the endothelial nitric oxide synthase promoter in endothelial cells, indicating that Brg1 is beneficial in maintaining the vascular tone under stress conditions. These discrepancies reflect the gene-, cell-, and signal-specific nature of transcriptional regulation mediated by Brg1/Brm and need to be clarified by further research.
One of the intriguing issues regarding regulation of human pathobiology by Brg1 and Brm is their functional redundancy, that is, how well one can compensate for the loss of the other both in embryogenesis and adult life. Brg1 and Brm clearly assume opposing roles in osteoblast differentiation. 28 On the other hand, although Brm null mice are viable and slightly overweight due to increased cell proliferation, whole-body or tissue-specific Brg1 deletion causes lethality in mice, arguing for the irreplaceable role of Brg1 and as such lending support to the notion that Brm is nonessential in organogenesis especially in the cardiovascular system. 13, [29] [30] [31] [32] [33] There has been, however, few definitive reports dissecting the role of Brg1 and Brm in postembryonic life. In hepatocyte, Brm, but not Brg1, is required for hypoxia-induced transactivation of the erythropoietin gene and for the activation of Cyp7a1 gene in cholesterol metabolism. 34, 35 Hang et al 13 demonstrated, by using a tetracycline-inducible system that switches off Brg1 expression in the heart in adult mice, that Brg1 depletion greatly improves, but not completely abolishes, pressure overload-induced cardiac hypertrophy, leaving open the question whether Brm could be responsible for the residual cardiomyocyte oversize observed in these mice. In the present study, we have observed that Brg1 and Brm play differential roles in regulating CAM transcription in response to different stimuli. For instance, knock down of Brg1 does not seem to abrogate completely VCAM promoter activity/mRNA induced by TNF to basal levels ( Figure 3A and 3B) ; on the other hand, Brg1 siRNA dramatically downregulates VCAM mRNA levels induced by LPS to below basal levels (Online Figure IIIG) . This clearly reflects the complicated interplay between Brg1/Brm, specific gene/chromatin structure, and the upstream signal. Several key factors may contribute to the target specificity and hence biological relevance for Brg1 and Brm. Structurally, Brg1 differs from Brm in that Brg1 possesses a unique N-terminal domain that confers to Brg1 the ability to interact with and be recruited by zinc finger-type transcription factors such as Kruppel like factor and GATA. 36 Alternatively, tissuespecific expression/distribution of Brg1 and Brm may also play a role in their dedicated functionality. Compared with Brg1 that is preferentially expressed in epithelial cells, Brm expression is more enriched in smooth muscle and endothelial cells in healthy humans. 37 It is noteworthy that under pathological conditions, the expression patterns of Brg1 and Brm could be significantly altered (Figure 1; Online Figure I ). We 38 Recently, it has been demonstrated that smooth muscle cell-specific knockout of Brg1 on a Brm-null background led to increased neonatal death and an aggravated phenotype in surviving mice, strongly supporting a Brg1-independent role for Brm in the vasculature in vivo. 32 Because we targeted both Brg1 and Brm in our animal models, it remains to be determined whether they contribute differentially to inflammation-inflicted endothelial injury in vivo. High-throughput ChIP-seq profiling of Brg1/Brm binding in endothelial cells under different stress cues (LPS versus TNFα) will enable a thorough analysis of the differential contribution of Brg1/Brm to gene expression. Our data also revealed some subtle differences between Brg1 and Brm in terms of CAM transactivation by TNF-α. For instance, Brm induced VCAM-1 and E-selectin promoter activities better than Brg1 in the presence of TNF-α ( Figure 2A ). As shown in Figure 1C and 1E, endogenous Brm levels seem to be lower than endogenous Brg1 levels, possibly rendering the cells more sensitive to the introduction of exogenous Brm than to Brg1 in terms of promoter activity. On the other hand, it is noteworthy that we used partial deletions of the CAM promoter constructs (ICAM-1, −393/+42; VCAM-1, −519/+20; and E-selectin, −188/+25) with the NF-κB-binding motif included, which may not give the whole picture wherein Brg1/Brm regulates endogenous gene transcription. Indeed, endogenous VCAM-1 and E-selectin mRNA ( Figure 2C ) and protein ( Figure 2D ) levels respond to Brg1 overexpression and Brm overexpression equally well. The only way to compare the postembryonic functionalities of Brg1 and Brm in the endothelium would be to generate an inducible (eg, dox or estrogen) Cre line similar to the one used by Hang et al. 13 To our best knowledge, the results as summarized in this article represent heretofore the first direct evidence that links Brg1/Brm-dependent CAM transactivation in endothelial cells to the pathogenesis of atherosclerosis (Figure 7 ) in mice. Brg1 and Brm have been shown to exert cell-specific effects in the cardiovascular system. 11, 13, 32 Therefore, nonselective depletion of Brg1/Brm in vivo might have engendered equivocal data interpretation. For instance, atherosclerosis is widely believed pathology of inflammation. It is conceivable that macrophagespecific Brg1/Brm, rather than endothelial-specific Brg1/Brm, contributes to atherogenesis because Brg1 and Brm are essential for NF-αB/p65-dependent production of IL-1, IL-6, and MCP-1. 11, 22 Our endothelial-specific Brg1/Brm targeting system has largely avoided these potential ambiguities. Still, a recent investigation by Griffin et al 39 identified the Wnt/βcatenin pathway as a downstream target for Brg1. Because aberrant activation of Wnt/β-catenin signaling has been correlated with atherosclerosis, 40, 41 decelerated atherogenesis in mice without Brg1/Brm could stem from suppression of βcatenin activity.
In conclusion, our data suggest that Brg1/Brm serves as the common link that connects inflammation-induced endothelial injury to the pathogenesis of atherosclerosis by coordinating epigenetic regulation of NF-κB-dependent CAM transactivation. In light of the observation that Brg1 inactivation in the heart protects against pathological cardiac hypertrophy in mice, 13 our findings reinforce the notion that (inadvertent) reactivation of certain genes (eg, Brg1) required for embryonic development may pose great health risk in adult life. Therefore, targeting Brg1/Brm may offer new hope in the prevention or intervention of cardiovascular disorders.
